Value evidence synthesis and analysis

Understanding and communicating impactful value evidence has never been more important. With growing numbers of therapies being approved through fast-track processes, in addition to targeted therapies in rare diseases areas, we recognize that clinical trial data is increasingly complex and that it may require augmenting with additional evidence to meet payer needs. Our team can support with:

Conducting systematic literature reviews and indirect treatment comparisons to synthesize the available published evidence

Determining the feasibility and most appropriate approach for evidence synthesis to support market access at national and local levels

Analysing your clinical trial data to meet the needs of payers and reimbursement bodies and to ensure appropriate statistical approaches are taken for inclusion in economic models

View a case study on a previous value evidence synthesis and analysis project

A network meta-analysis of randomised controlled trials in dementia with Lewy bodies

Health Economics & Data Analysis

Click here for details of our wider expertise and our database of published research and conference presentations